Haleon (HLN) vs Stepan (SCL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Stepan (SCL) has outperformed Haleon (HLN) over the past year, gaining 43.8% versus a loss of 8.1%. Haleon is the larger company by market cap ($39.76 billion vs $1.44 billion), about 27.5 times the size. On valuation, Haleon trades at a lower forward P/E (15.0x vs 18.0x for Stepan).
Stepan offers the higher dividend yield (2.49% vs 0.80%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HLN | SCL |
|---|---|---|
| Share price | $9.07 | $63.48 |
| Market cap | $39.76B | $1.44B |
| 1-day change | +0.22% | -2.34% |
| YTD return | -10.29% | +34.04% |
| 1-year return | -8.11% | +43.85% |
| 5-year return | — | -46.34% |
| P/E ratio (TTM) | 18.51 | 334.11 |
| Forward P/E | 15.01 | 18.03 |
| EPS (TTM) | $0.49 | $0.19 |
| Dividend yield | 0.80% | 2.49% |
| Annual dividend | $0.073 | $1.58 |
| Revenue (latest FY) | — | $2.33B |
| Revenue growth (YoY) | — | +6.96% |
| Net income (latest FY) | — | $46.90M |
| Gross margin | — | 11.57% |
| Operating margin | — | 3.37% |
| Net margin | — | 2.01% |
| 52-week high | $11.28 | $72.67 |
| 52-week low | $8.38 | $43.00 |
| Distance from 52-week high | -19.59% | -12.65% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +14.66% | +33.90% |
| Average volume | 19.19M | 152.47K |
| Shares outstanding | 4.38B | 22.73M |
| Employees | 24,535 | 2,328 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Package Goods/Cosmetics | Package Goods/Cosmetics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Haleon is about 27.5 times larger than Stepan by market value ($39.76B vs $1.44B).
- SCL has outperformed HLN by 52.0 percentage points over the past year.
- Stepan trades at a higher earnings multiple (334.1x vs 18.5x trailing P/E).
- Stepan offers a meaningfully higher dividend yield (2.49% vs 0.80%).
About Haleon
HLN stock →Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Consumer Discretionary · Package Goods/Cosmetics · 24,535 employees
About Stepan
SCL stock →Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products.
Consumer Discretionary · Package Goods/Cosmetics · 2,328 employees
HLN vs SCL FAQ
Which is bigger, Haleon or Stepan?
Haleon (HLN) is larger, with a market capitalization of $39.76B compared with $1.44B for Stepan (SCL).
Which stock has performed better over the past year, HLN or SCL?
SCL returned +43.85% over the past 12 months, compared with -8.11% for HLN (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, HLN or SCL?
HLN has the lower trailing P/E at 18.5, versus 334.1 for SCL. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Haleon or Stepan?
Stepan has the higher yield at 2.49%, compared with 0.80% for Haleon.
Are Haleon and Stepan in the same industry?
Yes. Both are classified in the Package Goods/Cosmetics industry within the Consumer Discretionary sector.